Furthermore, CD276-pyrrolobenzodiazepine increased event-free survival with exceptional responses in PDX models of embryonal and alveolar rhabdomyosarcoma and Ewing sarcoma [227]. This evidence concerns the gene CD276 and rhabdomyosarcoma.